|
1
|
Scalo JF and Rascati KL: Trends and issues
in oncology costs. Expert Rev Pharmacoecon Outcomes Res. 14:35–44.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Enewold L, Horner MJ, Shriver CD and Zhu
K: Socioeconomic disparities in colorectal cancer mortality in the
United States, 1990–2007. J Community Health. 39:760–766. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dienstmann R, Salazar R and Tabernero J:
Personalizing colon cancer adjuvant therapy: Selecting optimal
treatments for individual patients. J Clin Oncol. 33:1787–1796.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Randén M, Helde-Frankling M, Runesdotter S
and Strang P: Treatment decisions and discontinuation of palliative
chemotherapy near the end-of-life, in relation to socioeconomic
variables. Acta Oncol. 52:1062–1066. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Guadagnolo BA, Liao KP, Elting L, Giordano
S, Buchholz TA and Shih YC: Use of radiation therapy in the last 30
days of life among a large population-based cohort of elderly
patients in the United States. J Clin Oncol. 31:80–87. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Murphy JD, Nelson LM, Chang DT, Mell LK
and Le QT: Patterns of care in palliative radiotherapy: A
population-based study. J Oncol Pract. 9:e220–e227. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kapadia NS, Mamet R, Zornosa C, Niland JC,
D'Amico TA and Hayman JA: Radiation therapy at the end of life in
patients with incurable nonsmall cell lung cancer. Cancer.
118:4339–4345. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gripp S, Mjartan S, Boelke E and Willers
R: Palliative radiotherapy tailored to life expectancy in end-stage
cancer patients: Reality or myth? Cancer. 116:3251–3256. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hartsell WF, Desilvio M, Bruner DW,
Scarantino C, Ivker R, Roach M III, Suh J, Demas WF, Movsas B,
Petersen IA and Konski AA: Can physicians accurately predict
survival time in patients with metastatic cancer? Analysis of RTOG
97–14. J Palliat Med. 11:723–728. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Angelo K, Norum J, Dalhaug A, Pawinski A,
Aandahl G, Haukland E, Engljähringer K and Nieder C: Development
and validation of a model predicting short survival (death within
30 days) after palliative radiotherapy. Anticancer Res. 34:877–885.
2014.PubMed/NCBI
|
|
11
|
Langley RE, Stephens RJ, Nankivell M, Pugh
C, Moore B, Navani N, Wilson P, Faivre-Finn C, Barton R, Parmar MK
and Mulvenna PM: QUARTZ Investigators: Interim data from the
Medical Research Council QUARTZ Trial: Does whole brain
radiotherapy affect the survival and quality of life of patients
with brain metastases from non-small cell lung cancer? Clin Oncol
(R Coll Radiol). 25:e23–e30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nieder C, Andratschke N, Angelo K,
Haukland E and Grosu AL: Development of a score predicting survival
after palliative reirradiation. J Oncol. 2014:1282402014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ramchandran KJ, Shega JW, Von Roenn J,
Schumacher M, Szmuilowicz E, Rademaker A, Weitner BB, Loftus PD,
Chu IM and Weitzman S: A predictive model to identify hospitalized
cancer patients at risk for 30-day mortality based on admission
criteria via the electronic medical record. Cancer. 119:2074–2080.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nieder C, Norum J, Dalhaug A, Aandahl G
and Pawinski A: Radiotherapy versus best supportive care in
patients with brain metastases and adverse prognostic factors. Clin
Exp Metastasis. 30:723–729. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cameron MG, Kersten C, Vistad I, Fosså S
and Guren MG: Palliative pelvic radiotherapy of symptomatic
incurable rectal cancer - a systematic review. Acta Oncol.
53:164–173. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Laugsand TS, Kaasa S, Romundstad P,
Johannesen TB and Lund JÅ: Radiotherapy for bone metastases:
Practice in Norway 1997–2007. A national registry-based study. Acta
Oncol. 52:1129–1136. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
van Oorschot B, Schuler M, Simon A,
Schleicher U and Geinitz H: Patterns of care and course of symptoms
in palliative radiotherapy: A multicenter pilot study analysis.
Strahlenther Onkol. 187:461–466. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
van Oorschot B, Rades D, Schulze W,
Beckmann G and Feyer P: Palliative radiotherapy - new approaches.
Semin Oncol. 38:443–449. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Anshushaug M, Gynnild MA, Kaasa S,
Kvikstad A and Grønberg BH: Characterization of patients receiving
palliative chemo- and radiotherapy during end of life at a regional
cancer center in Norway. Acta Oncol. 54:395–402. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Leth T, von Oettingen G, Lassen-Ramshad
YA, Lukacova S and Høyer M: Survival and prognostic factors in
patients treated with stereotactic radiotherapy for brain
metastases. Acta Oncol. 54:107–114. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jang RW, Caraiscos VB, Swami N, Banerjee
S, Mak E, Kaya E, Rodin G, Bryson J, Ridley JZ, Le LW and
Zimmermann C: Simple prognostic model for patients with advanced
cancer based on performance status. J Oncol Pract. 10:e335–e341.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen AB, Cronin A, Weeks JC, Chrischilles
EA, Malin J, Hayman JA and Schrag D: Expectations about the
effectiveness of radiation therapy among patients with incurable
lung cancer. J Clin Oncol. 31:2730–2735. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sharma S, Hertan L and Jones J: Palliative
radiotherapy: Current status and future directions. Semin Oncol.
41:751–763. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lutz ST, Jones J and Chow E: Role of
radiation therapy in palliative care of the patient with cancer. J
Clin Oncol. 32:2913–2919. 2014. View Article : Google Scholar : PubMed/NCBI
|
